Alan Garber
Affiliations: | Stanford University, Palo Alto, CA | ||
| Harvard University, Cambridge, MA, United States |
Google:
"Alan Garber"Parents
Sign in to add mentor| Martin Feldstein | grad student | ||
| Zvi Griliches | grad student | ||
| Richard J. Zeckhauser | grad student | (History of History Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Foster JG, Wood SK, Pfeffer MA, et al. (2018) ASPIRIN FOR PRIMARY PREVENTION IN PATIENTS WITH TYPE 2 DIABETES. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists |
| Freeman JV, Hutton DW, Barnes GD, et al. (2016) Cost-Effectiveness of Percutaneous Closure of the Left Atrial Appendage in Atrial Fibrillation Based on Results From PROTECT AF Versus PREVAIL. Circulation. Arrhythmia and Electrophysiology. 9 |
| Khazeni N, Hutton DW, Collins CI, et al. (2014) Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Annals of Internal Medicine. 160: 684-94 |
| Bach RG, Brooks MM, Lombardero M, et al. (2014) Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Circulation. 129: e460-1 |
| Kazi DS, Garber AM, Shah RU, et al. (2014) Cost-effectiveness of genotype-guided and dual antiplatelet therapies in acute coronary syndrome. Annals of Internal Medicine. 160: 221-32 |
| Simons CT, Cipriano LE, Shah RU, et al. (2013) Transcatheter aortic valve replacement in nonsurgical candidates with severe, symptomatic aortic stenosis: a cost-effectiveness analysis. Circulation. Cardiovascular Quality and Outcomes. 6: 419-28 |
| Erickson KF, Japa S, Owens DK, et al. (2013) Cost-effectiveness of statins for primary cardiovascular prevention in chronic kidney disease. Journal of the American College of Cardiology. 61: 1250-8 |
| Garber A, Abrahamson M, Barzilay J, et al. (2013) American association of clinical endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement Endocrine Practice. 19: 1-48 |
| Kazi D, Garber AM, Shah R, et al. (2012) PANACEA OR PERSONALIZED MEDICINE? OPTIMIZING ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME – A COST-EFFECTIVENESS ANALYSIS Journal of the American College of Cardiology. 59: E348 |
| Sharma MD, Farmer JA, Garber A. (2011) Type 2 diabetes and cardiovascular risk factors. Current Medical Research and Opinion. 27: 1-5 |